SARS-CoV-2 Nucleocapsid anticorps
-
- Antigène Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Anticorps
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Reactivité
- SARS Coronavirus-2 (SARS-CoV-2)
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp SARS-CoV-2 Nucleocapsid est non-conjugé
-
Application
- ELISA, Western Blotting (WB), Immunofluorescence (IF)
- Specificité
- Specific for the nucleoprotein of the SARS virus.
- Purification
- SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleoprotein antibody is purified from ascites fluid or culture medium by protein A chromoatography or sequential differential precipitations.
- Clone
- 3861
- Isotype
- IgG1
- Top Product
- Discover our top product SARS-CoV-2 N Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- phosphate saline buffer (0.01M, pH 7.2) containing 0.1 % sodium azide preservative. No stabilizing proteins have been added.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- antibody can be stored at -20°C, stable for one year.
- Date de péremption
- 12 months
-
-
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds." dans: Frontiers in immunology, Vol. 11, pp. 573526, (2020) (PubMed).
: "
-
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds." dans: Frontiers in immunology, Vol. 11, pp. 573526, (2020) (PubMed).
-
- Antigène
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- Autre désignation
- SARS-CoV-2 Nucleocapsid Protein (SARS-CoV-2 N Produits)
- Synonymes
- anticorps nucleocapsid phosphoprotein, anticorps N
- Classe de substances
- Viral Protein
-